Luc Bruyndonckx

Prof. Dr. Luc Bruyndonckx

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Pediatrics
Verified
Journal Article
Open access
PDF file
LBLuc Bruyndonckx
Luc Bruyndonckx
VHVicky Y. Hoymans
Vicky Y. Hoymans
AGAnn De Guchtenaere
Ann De Guchtenaere
MHMaria Van Helvoirt
Maria Van Helvoirt
ECEmeline M. Van Craenenbroeck
Emeline M. Van Craenenbroeck
VCViviane M. Conraads
Viviane M. Conraads
OBJECTIVE: To determine the risk for psychiatric disorders among extremely low birth weight (ELBW) survivors in their early to mid-30s and to determine whether those born small for gestational age or those exposed to a full course of antenatal corticosteroids (ACS) were at particularly high risk. METHODS: A prospective, longitudinal, population-based cohort of 84 ELBW survivors and 90 normal birth weight (NBW) control participants born in Ontario, Canada from 1977 to 1982 were assessed by interviewers naive to birth weight status using the Mini-International Neuropsychiatric Interview. RESULTS: ELBW survivors had lower odds of an alcohol or substance use disorder but higher odds of current non–substance-related psychiatric problems (odds ratio [OR] = 2.47; 95% confidence interval [CI], 1.19–5.14). Those born ELBW and SGA exhibited the same patterns with larger effects. ACS-exposed ELBW survivors had even higher odds of any current non–substance-related psychiatric disorder (OR = 4.41; 95% CI, 1.65–11.82), particularly generalized anxiety disorder (OR = 3.42; 95% CI, 1.06–11.06), the generalized type of social phobia (OR = 5.80; 95% CI, 1.20–27.99), and the inattentive subtype of attention-deficit/hyperactivity disorder (OR = 11.45; 95% CI, 2.06–63.50). CONCLUSIONS: In their early to mid-30s, ELBW survivors were less likely to have alcohol or substance use disorders but may be at greater risk for other psychiatric problems. Those exposed to ACS were at especially high risk and manifested no reduction in alcohol or substance use disorders. ELBW survivors exposed to ACS may be a special group at risk for psychopathology in adulthood.

1 September 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
ECEmeline M. Van Craenenbroeck
Emeline M. Van Craenenbroeck
ACAmaryllis H Van Craenenbroeck
Amaryllis H Van Craenenbroeck
SISabrina van Ierssel
Sabrina van Ierssel
LBLuc Bruyndonckx
Luc Bruyndonckx
VHVicky Y. Hoymans
Vicky Y. Hoymans
VCViviane M. Conraads
Viviane M. Conraads

1 January 2013 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LBLuc Bruyndonckx
Luc Bruyndonckx
VHVicky Y. Hoymans
Vicky Y. Hoymans
ACAmaryllis H Van Craenenbroeck
Amaryllis H Van Craenenbroeck
DVDirk Vissers
Dirk Vissers
CVChristiaan J. Vrints
Christiaan J. Vrints
VCViviane M. Conraads
Viviane M. Conraads
The association of obesity with noncommunicable diseases, such as cardiovascular complications and diabetes, is considered a major threat to the management of health care worldwide. Epidemiological findings show that childhood obesity is rapidly rising in Western society, as well as in developing countries. This pandemic is not without consequences and can affect the risk of future cardiovascular disease in these children. Childhood obesity is associated with endothelial dysfunction, the first yet still reversible step towards atherosclerosis. Advanced research techniques have added further insight on how childhood obesity and associated comorbidities lead to endothelial dysfunction. Techniques used to measure endothelial function were further brought to perfection, and novel biomarkers, including endothelial progenitor cells, were discovered. The aim of this paper is to provide a critical overview on bothin vivoas well asin vitromarkers for endothelial integrity. Additionally, an in-depth description of the mechanisms that disrupt the delicate balance between endothelial damage and repair will be given. Finally, the effects of lifestyle interventions and pharmacotherapy on endothelial dysfunction will be reviewed.

1 October 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
LBLuc Bruyndonckx
Luc Bruyndonckx
TRThomas Radtke
Thomas Radtke
PEPrisca Eser
Prisca Eser
CVChristiaan J. Vrints
Christiaan J. Vrints
JRJosé Ramet
José Ramet
VCViviane M Conraads
Viviane M Conraads

11 February 2016 in Pediatric Research
Verified
Journal Article
Closed access
LBLuc Bruyndonckx
Luc Bruyndonckx
VHVicky Y Hoymans
Vicky Y Hoymans
KLKatrien Lemmens
Katrien Lemmens
JRJosé Ramet
José Ramet
CVChristiaan J Vrints
Christiaan J Vrints

1 August 2014 in The Journal of Pediatrics
Verified
Journal Article
Closed access
LBLuc Bruyndonckx
Luc Bruyndonckx
VHVicky Y. Hoymans
Vicky Y. Hoymans
GFGeert Frederix
Geert Frederix
AGAnn De Guchtenaere
Ann De Guchtenaere
HFHilde Franckx
Hilde Franckx
VCViviane M. Conraads
Viviane M. Conraads